Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+NSCLC: Primary Analysis from JAVELIN Lung 100


Reck M., Barlesi F., Yang J. C. -., Westeel V., Felip E., ÖZGÜROĞLU M., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.17, no.9, 2022 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 17 Issue: 9
  • Publication Date: 2022
  • Journal Name: JOURNAL OF THORACIC ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Keywords: avelumab, NSCLC, first-line
  • Istanbul University Affiliated: No